Analytical Data
-
基因名
ANXA13
- Application
-
别名
ANXA13；ANX13；Annexin A13
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P27216
-
表达区间
1-316aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMGNRHAKASSPQGFDVDRDAKKLNKACKGM GTNEAAIIEILSGRTSDERQQIKQKYKATYGKELEEVLKSELSGNFEKTA LALLDRPSEYAARQLQKAMKGLGTDESVLIEVLCTRTNKEIIAIKEAYQR LFDRSLESDVKGDTSGNLKKILVSLLQANRNEGDDVDKDLAGQDAKDLYD AGEGRWGTDELAFNEVLAKRSYKQLRATFQAYQILIGKDIEEAIEEETSG DLQKAYLTLVRCAQDCEDYFAERLYKSMKGAGTDEETLIRIVVTRAEVDL QGIKAKFQEKYQKSLSDMVRSDTSGDFRKLLVALLH
-
分子量
38 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANXA13, or annexin A13, is a member of the annexin family of proteins, which are known for their role in various cellular processes, including membrane trafficking, cell signaling, and apoptosis. Recent studies have highlighted the significance of ANXA13 in various physiological and pathological conditions, such as cellular responses to stress and inflammation, as well as its potential involvement in cancer development and progression. The protein is characterized by its unique structure, consisting of multiple annexin repeats that mediate calcium-dependent binding to phospholipids, contributing to its diverse biological functions. Understanding the mechanism by which ANXA13 operates opens avenues for potential therapeutic applications, particularly in diseases characterized by aberrant cellular signaling and membrane dynamics. Given the increasing interest in the role of annexins in cell biology, the recombinant expression of ANXA13 provides a valuable tool for in vitro studies, allowing researchers to investigate its functional properties and interactions with other cellular components. This research not only aims to elucidate the specific roles of ANXA13 in various cellular contexts but also seeks to identify potential biomarkers for disease states and novel targets for drug development. As the field progresses, the continued characterization of ANXA13 through recombinant protein studies could pave the way for innovative therapeutic strategies aimed at modulating its activity in disease contexts.
